A few weeks after its purchase of Pfizer's citric acid business, ADM arranged several bilateral meetings with other citric acid manufacturers, ostensibly for the purpose of introducing itself to its competitors.
Recital 74, Decision_act (EU) 2002/742
In forcesince 5 Dec 2001